The tennis star has sparked an online debate about whether or not using GLP-1s for weight loss is taking the easy way out.

New gene therapies that can come with a one-time cost of more than $2 million also are having an impact, insurance brokers ...

Millions of Americans who have dropped pounds and boosted their health using popular obesity drugs like Wegovy are facing a ...

Jameela Jamil is clarifying her previous statement regarding Serena Williams and GLP-1s. Here's what she said.

Celebrities have access to doctors that most others don’t,” Jameela Jamil flags the risks of GLP-1s like those Serena ...

In a recent video spot, the 43-year-old athlete reveals that Ro helped her lose 31 pounds in eight months. “Yes, I’m on Ro.

Burke Wealth Management, an investment management company, released its “Focused Growth Strategy” second-quarter 2025 ...

About 12% of all U.S. adults have already tried using GLP-1 agonist drugs to control their weight, according to a survey ...

Pricey prescriptions and nagging medical costs are swamping some insurers and employers now. Patients may start paying for it next year.

Eli Lilly and Novo Nordisk already make popular GLP-1s in the Triangle. A Swiss drugmaker says its future Wake County site will, too.